MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

An update from MEI Pharma ( (MEIP) ) is now available.

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional ...

In other recent news, MEI Pharma, Inc. has announced a significant financial strategy shift involving a $100 million private placement aimed at establishing a Litecoin treasury reserve.

SAN DIEGO - MEI Pharma, Inc. (NASDAQ:MEIP), whose stock has surged over 113% in the past week to $6.86, has closed a $100 million private placement and announced plans to become the first publicly ...

MEI Pharma (MEIP) shares soared Friday premarket as it unveiled a $100 million private placement to fund its new Litecoin treasury strategy, marking a groundbreaking shift in corporate crypto ...

MEI Pharma, Inc. (NASDAQ:MEIP) is one of the hot penny stocks to invest in now. On July 18, MEI Pharma, Inc.

Litecoin ETF approval talk grows as institutional interest rises, fueled by regulatory clarity and LTC’s increasing role in ...